annual EBITDA:
-$216.24M-$73.03M(-51.00%)Summary
- As of today (July 1, 2025), KYMR annual EBITDA is -$216.24 million, with the most recent change of -$73.03 million (-51.00%) on December 31, 2024.
- During the last 3 years, KYMR annual EBITDA has fallen by -$118.59 million (-121.45%).
- KYMR annual EBITDA is now -917.77% below its all-time high of -$21.25 million, reached on December 31, 2018.
Performance
KYMR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$63.46M+$5.25M(+7.63%)Summary
- As of today (July 1, 2025), KYMR quarterly EBITDA is -$63.46 million, with the most recent change of +$5.25 million (+7.63%) on March 31, 2025.
- Over the past year, KYMR quarterly EBITDA has dropped by -$16.43 million (-34.95%).
- KYMR quarterly EBITDA is now -749.77% below its all-time high of -$7.47 million, reached on September 30, 2020.
Performance
KYMR quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$232.67M-$16.43M(-7.60%)Summary
- As of today (July 1, 2025), KYMR TTM EBITDA is -$232.67 million, with the most recent change of -$16.43 million (-7.60%) on March 31, 2025.
- Over the past year, KYMR TTM EBITDA has dropped by -$82.44 million (-54.87%).
- KYMR TTM EBITDA is now -1966.71% below its all-time high of -$11.26 million, reached on September 30, 2019.
Performance
KYMR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
KYMR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -51.0% | -35.0% | -54.9% |
| 3 y3 years | -121.5% | -76.5% | -92.2% |
| 5 y5 years | -435.6% | -503.8% | -400.7% |
KYMR EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -121.5% | at low | -372.7% | +7.6% | -70.5% | at low |
| 5 y | 5-year | -435.6% | at low | -749.8% | +7.6% | -445.2% | at low |
| alltime | all time | -917.8% | at low | -749.8% | +7.6% | -1966.7% | at low |
KYMR EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$63.46M(-7.6%) | -$232.67M(+7.6%) |
| Dec 2024 | -$216.24M(+51.0%) | -$68.71M(+13.7%) | -$216.24M(+34.3%) |
| Sep 2024 | - | -$60.44M(+50.9%) | -$160.96M(+5.6%) |
| Jun 2024 | - | -$40.06M(-14.8%) | -$152.45M(+1.5%) |
| Mar 2024 | - | -$47.03M(+250.3%) | -$150.23M(+4.9%) |
| Dec 2023 | -$143.20M(-5.6%) | -$13.43M(-74.1%) | -$143.20M(-12.6%) |
| Sep 2023 | - | -$51.93M(+37.2%) | -$163.76M(+6.3%) |
| Jun 2023 | - | -$37.85M(-5.4%) | -$154.03M(-1.1%) |
| Mar 2023 | - | -$39.99M(+17.7%) | -$155.69M(+2.7%) |
| Dec 2022 | -$151.66M | -$33.99M(-19.5%) | -$151.65M(+0.5%) |
| Sep 2022 | - | -$42.20M(+6.8%) | -$150.83M(+10.5%) |
| Jun 2022 | - | -$39.51M(+9.9%) | -$136.47M(+12.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$35.96M(+8.4%) | -$121.04M(+24.0%) |
| Dec 2021 | -$97.64M(+123.4%) | -$33.16M(+19.1%) | -$97.65M(+27.4%) |
| Sep 2021 | - | -$27.84M(+15.6%) | -$76.65M(+36.2%) |
| Jun 2021 | - | -$24.08M(+91.6%) | -$56.27M(+23.0%) |
| Mar 2021 | - | -$12.57M(+3.3%) | -$45.77M(+4.7%) |
| Dec 2020 | -$43.72M(+8.3%) | -$12.16M(+62.8%) | -$43.72M(+2.4%) |
| Sep 2020 | - | -$7.47M(-45.0%) | -$42.68M(-8.2%) |
| Jun 2020 | - | -$13.57M(+29.2%) | -$46.47M(+41.3%) |
| Mar 2020 | - | -$10.51M(-5.5%) | -$32.89M(+47.0%) |
| Dec 2019 | -$40.38M(+90.0%) | -$11.12M(-1.2%) | -$22.38M(+98.8%) |
| Sep 2019 | - | -$11.26M | -$11.26M |
| Dec 2018 | -$21.25M | - | - |
FAQ
- What is Kymera Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Kymera Therapeutics?
- What is Kymera Therapeutics annual EBITDA year-on-year change?
- What is Kymera Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly EBITDA year-on-year change?
- What is Kymera Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Kymera Therapeutics?
- What is Kymera Therapeutics TTM EBITDA year-on-year change?
What is Kymera Therapeutics annual EBITDA?
The current annual EBITDA of KYMR is -$216.24M
What is the all time high annual EBITDA for Kymera Therapeutics?
Kymera Therapeutics all-time high annual EBITDA is -$21.25M
What is Kymera Therapeutics annual EBITDA year-on-year change?
Over the past year, KYMR annual EBITDA has changed by -$73.03M (-51.00%)
What is Kymera Therapeutics quarterly EBITDA?
The current quarterly EBITDA of KYMR is -$63.46M
What is the all time high quarterly EBITDA for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly EBITDA is -$7.47M
What is Kymera Therapeutics quarterly EBITDA year-on-year change?
Over the past year, KYMR quarterly EBITDA has changed by -$16.43M (-34.95%)
What is Kymera Therapeutics TTM EBITDA?
The current TTM EBITDA of KYMR is -$232.67M
What is the all time high TTM EBITDA for Kymera Therapeutics?
Kymera Therapeutics all-time high TTM EBITDA is -$11.26M
What is Kymera Therapeutics TTM EBITDA year-on-year change?
Over the past year, KYMR TTM EBITDA has changed by -$82.44M (-54.87%)